Catena Biosciences
company
About
Biotech company focused on protein conjugation.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $5M
- Industries
- Biotechnology,Life Science
- Founded date
- Nov 17, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Catena Biosciences is a biotech startup based on research from the Francis and Doudna labs at UC Berkeley focusing on the treatment and cure of autoimmune disorders. Catena’s platform differentiates on the ability to fuse proteins together using enzyme activation of native amino acids to create new treatments in oncology, autoimmune disorders and vaccine development!
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$5M
Catena Biosciences has raised a total of
$5M
in funding over 2 rounds. Their latest funding was raised on
Aug 1, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 1, 2021 | Seed | $5M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
